Tobias Brown
Family · Los Angeles, CANPI 1568122083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Viiv Healthcare Company at 44.0% of the total. 2025 is the largest year on record at $2,336, more than ten times the $191 reported in 2022. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $24.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$1K
- Neurocrine Biosciences, Inc.$243
- Merck$231
- EMD Serono, Inc.$227
- Lilly USA, LLC$141
- plus $549 from 15 others
What the payments were for
- Food & beverage$4,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 80 | $1,920 |
| Gilead | 41 | $1,049 |
| Neurocrine Biosciences, Inc. | 7 | $243 |
| Merck | 11 | $231 |
| EMD Serono, Inc. | 9 | $227 |
| Lilly USA, LLC | 5 | $141 |
| Hologic Sales And Service, LLC | 3 | $81 |
| Novo Nordisk | 4 | $74 |
| AbbVie | 3 | $72 |
| Napo Pharmaceuticals Inc | 2 | $65 |
| Johnson & Johnson | 2 | $37 |
| Bausch Health US, LLC | 1 | $26 |
| Amgen | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Theratechnologies Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $24 |
| GSK | 1 | $23 |
| AstraZeneca | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,360 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 18 | $263 |
| Atorvastatin Calcium | 32 | $216 |
| Losartan Potassium | 13 | $110 |
| Metformin Hcl | 20 | $95 |
| Amlodipine Besylate | 29 | $92 |
| Clotrimazole | 11 | $54 |
| Cyclobenzaprine Hcl | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other family in Los Angeles
- Annette ShonLos Angeles$406K
- Phyllis CasonLos Angeles$187K
- Theodore SolomonLos Angeles$131K
- Angela SarffLos Angeles$51K
- Karla MenjivarLos Angeles$36K
- Janet GripshoverLos Angeles$30K
- Jualynda SmithLos Angeles$28K
- Phoebedel ReyesLos Angeles$26K
- Ayana ElliottLos Angeles$25K
- Lori RobertsonChino Hills$475K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.